Viveve Medical (VIVE) Misses Q2 EPS by 11c, Miss on Revenues

Viveve Medical (NASDAQ: VIVE) reported Q2 EPS of ($0.54), $0.11 worse than the analyst estimate of ($0.43). Revenue for the quarter came in at $3.1 million versus the consensus estimate of $3.24 million.

For earnings history and earnings-related data on Viveve Medical (VIVE) click here.

You May Also Be Interested In

• Rent the Runway (RENT) Reports Q2 Loss of $0.38/sh
• Shoe Station Group Inc. (SHOE) Tops Q2 EPS by 11c ; Offers Guidance
• Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance